Search results
Insiders At Moderna Sold US$3.3m In Stock, Alluding To Potential Weakness
Simply Wall St. via Yahoo Finance· 1 hour agoIn the last year, many Moderna, Inc. (NASDAQ:MRNA) insiders sold a substantial stake in the company...
25,274 Shares in Moderna, Inc. (NASDAQ:MRNA) Bought by Los Angeles Capital Management LLC
ETF DAILY NEWS· 6 hours agoLos Angeles Capital Management LLC acquired a new position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) during the 1st quarter, according to its most recent 13F ...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 2 weeks agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Why Moderna Stock Is a No-Brainer Buy Right Now
Motley Fool via Yahoo Finance· 2 weeks agoSome investors might view Moderna (NASDAQ: MRNA) as a shooting star that shined bright for a while then flamed out. In 2022, the biotech company...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 2 weeks agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Zacks via Yahoo Finance· 2 weeks agoModerna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...
Moderna's COVID-Flu Vaccine Shows Stronger Immune Response Than Individual Shots, Late-Stage Trial...
Forbes· 2 weeks agoModerna on Monday said its combination COVID-19 and flu shot elicits a stronger immune response...
Moderna COVID/flu combo vaccine superior to separate shots in trial
Reuters· 2 weeks ago, opens new tab said on Monday its combination vaccine to protect against both COVID-19 and...
Moderna Falls, Though Says Covid/Flu Shot Topped Rivals
Investor's Business Daily· 2 weeks agoIn a study of about 8,000 people, Moderna's combination vaccine proved it's not inferior to the...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoModerna stock is making a turnaround after the Food and Drug Administration approved its second-ever...